Pharmacist-Administered Influenza Immunizations: Staying One Jab Ahead of the Flu Season
This activity is supported by an educational grant from MedImmune Biologics Inc, Novartis Vaccines, and Sanofi Pasteur US.
Shilpa Amara, PharmD
Drug Information Specialist Barnabas Health South Plainfield, New Jersey
Henry Leach, PharmD
Pharmacy Resident Barnabas Health Behavioral Health Center Toms River, New Jersey
The following contributors have no relevant financial relationships with commercial interests to disclose.
Shilpa Amara, PharmD Henry Leach, PharmD Rutgers University, Ernest Mario School of Pharmacy Planning Staff Evelyn R. Hermes-DeSantis, PharmD, BCPS, Clinical Professor, Chair, Continuing Education Committee Mary Barna Bridgeman, PharmD, BCPS, CGP, Clinical Assistant Professor, Co-Chair, Continuing Education Committee
Pharmacy Times Office of Continuing Professional Education Planning Staff Judy V. Lum, MPA, and Elena Beyzarov, PharmD
Pharmacy Times Editorial Staff Kirk McKay and David Allikas
An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Upon completion of the educational activity, the participant should be able to:
- Examine the burden of influenza and patient populations at risk for influenza-related complications.
- Discuss currently available influenza vaccinations and interpret the most current influenza immunization schedule.
- Analyze the legal, regulatory, and liability issues involved with pharmacy-based immunization programs.
- Review proper vaccine dose preparation and injection technique.
- Describe the signs and symptoms of adverse reactions that can occur after vaccination and understand emergency procedures for adverse event management.
Target audience: Pharmacists
Type of activity: Knowledge
Release date: August 12, 2013
Expiration date: August 12, 2015
Estimated time to complete activity: 2 hours
Click here to view this lesson.